Author

N.L. Liberato

Observed names: N L Liberato, N Liberato, N. L. Liberato, NL Liberato

Institution: Azienda Socio Sanitaria Territoriale di Pavia

Observed institutions: University of Pavia, Antwerp University Hospital, European Organisation for Research and Treatment of Cancer, Policlinico San Matteo Fondazione, Azienda Socio Sanitaria Territoriale di Pavia

OpenAlex ID: A5111620417

Heparin treatment in sinus venous thrombosis

1991 · T.P. Enevoldson, R.W. Ross Russell, et al. · The Lancet · 92

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia

1998 · G Barosi, M Marchetti, et al. · British Journal of Cancer · 84

Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.

1993 · G Barosi, A Ambrosetti, et al. · PubMed · 67

Cost-effectiveness of interferon alfa in chronic myelogenous leukemia.

1997 · N L Liberato, S Quaglini, et al. · Journal of Clinical Oncology · 34

Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost–utility analysis

2011 · N.L. Liberato, C. Rognoni, et al. · Annals of Oncology · 27

Autoimmune hemolytic anemia in multicentric Castleman's disease.

1996 · N L Liberato, P Bollati, et al. · PubMed · 16

Variations in Erythropoiesis and Serum Ferritin during Erythropoietin Therapy for Anaemia of End-Stage Renal Disease

2009 · G. Barosi, C. Merlo, et al. · Acta Haematologica · 5

Pcn5: First-line Therapy for Advanced Breast Cancer — Cost-effectiveness of Anastrozole Versus Tamoxifen

2001 · M Marchetti, N Liberato, et al. · Value in Health · 3

Kosteneffektivität der Interferontherapie bei chronisch myeloischer Leukämie

1999 · N. L. Liberato, G. Barosi · Der Onkologe · 1

Free Erythrocyte Protoporphyrin in Hemodialysis Patients Treated with Human Recombinant Erythropoietin

1991 · V. Piazza, F. Galli, et al. · Springer eBooks · 1

TPF versus PF as induction therapy in unresectable head and neck cancer: A pharmacoeconomic analysis

2009 · N. L. Liberato, L. Licitra, et al. · Journal of Clinical Oncology

Risk factors for elastic transformation in myelofibrosis with myeloid metaplasia (MMM)

1995 · Giovanni Barosi, Silvana Quaglini, et al.

Effetto citoriduttivo dell'alfa-interferon ricombinante in pazienti con mielofibrosi con metaplasia mieloide.

1990 · G. Barosi, N.L. Liberato, et al. · Haematologica

Works count: 13

Citation count: 330

H-index: 6

I10-index: 6